June 29 – 30, 2015
The WIN 2015 Symposium, a two-day symposium on precision cancer medicine offered by WIN Consortium, attracted delegates from 36 countries worldwide. The overarching theme this year was Novel targets, innovative agents, advanced technologies: A WINning strategy? This theme was elaborated in various plenary sessions with over 25 internationally renown speakers, a round table of global pharma and academic experts on Overcoming resistance through combined therapies, moderated by Richard L. Schilsky, ASCO’s Chief Medical Officer and WIN Consortium’s scientific advisory board chair, and poster presentations. Many presentations (PDF) and e-posters can be viewed on this website.
Keynote lectures were presented by John Mendelsohn, chairman WIN Consortium, on The Era of Precision Cancer Medicine: A worldwide effort and challenge, James Allison, The University of Texas MD Anderson Cancer Center, on Targeting immune mechanisms, Andrea Califano, Columbia University, on A systems biology approach to precision cancer medicine, James Doroshow, U.S. National Cancer Institute (NCI) on NCI’s precision medicine initiative for oncology, and Francesco Pignatti, European Medicines Agency (EMA) on The EMA adaptive pathways approach to improve timely access for patients to new medicines.
Richard L. Schilsky, ASCO’s Chief Medical Officer and Chairman of WIN Consortium’s SAB, moderated a lively round-table discussion of pharma and academic experts on Overcoming resistance through combined therapies.
WIN Consortium provided interim results of its ongoing WINTHER trial and details of its next-generation trials in non-small cell lung cancer. The latter are addressing non-small cell lung cancer at all stages of the disease aiming at dramatically improving overall survival: SPRING (biomarker-driven triple therapy in stage IIIB/IV disease), SUMMER (reduce relapse with dual- adjuvant therapy in stage IIb and IIIa) and BOOSTER (markers for early detection in stage I and IIa).
WIN Consortium encourages the submission of high-quality abstracts on precision cancer medicine by awarding best-poster awards to a few posters presented at the annual WIN Symposium. The two winners of an award this year are presented on the Best-poster awards page.
The next WIN Symposium is scheduled to take place in Paris, June 27-28, 2016.
Congress by design supported the client with a broad range of services, including delegate registration, abstract handling, faculty management, program development, supplier management such as venues, caterer, photographer, hotels, signage, exhibition set-up and meeting materials.